Everett Magann
Concepts (662)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy | 234 | 2025 | 2452 | 11.090 |
Why?
| Pregnancy Complications | 43 | 2025 | 380 | 10.290 |
Why?
| Amniotic Fluid | 33 | 2023 | 70 | 8.780 |
Why?
| Pregnancy Outcome | 64 | 2024 | 207 | 8.280 |
Why?
| Ultrasonography, Prenatal | 40 | 2023 | 160 | 7.770 |
Why?
| Obstetrics | 20 | 2022 | 84 | 5.360 |
Why?
| Premature Birth | 25 | 2023 | 146 | 5.300 |
Why?
| Oligohydramnios | 25 | 2023 | 41 | 5.080 |
Why?
| Cesarean Section | 42 | 2024 | 157 | 4.870 |
Why?
| Delivery, Obstetric | 32 | 2024 | 109 | 4.610 |
Why?
| Female | 252 | 2025 | 27081 | 4.420 |
Why?
| Gestational Age | 48 | 2024 | 373 | 3.740 |
Why?
| Prenatal Care | 12 | 2023 | 106 | 3.450 |
Why?
| Telemedicine | 12 | 2023 | 469 | 3.330 |
Why?
| Postpartum Hemorrhage | 12 | 2018 | 34 | 3.210 |
Why?
| Humans | 258 | 2025 | 50503 | 3.180 |
Why?
| Labor Stage, Third | 9 | 2018 | 19 | 3.160 |
Why?
| Polyhydramnios | 13 | 2019 | 24 | 2.960 |
Why?
| Infant, Newborn | 75 | 2024 | 2749 | 2.850 |
Why?
| Fetal Membranes, Premature Rupture | 7 | 2023 | 22 | 2.720 |
Why?
| Adult | 138 | 2024 | 13577 | 2.650 |
Why?
| Placenta | 8 | 2022 | 134 | 2.610 |
Why?
| Uterine Rupture | 5 | 2023 | 10 | 2.580 |
Why?
| Pre-Eclampsia | 14 | 2024 | 41 | 2.580 |
Why?
| Obstetric Labor Complications | 12 | 2020 | 25 | 2.540 |
Why?
| Hypertension, Pregnancy-Induced | 6 | 2024 | 15 | 2.410 |
Why?
| Fetal Diseases | 7 | 2022 | 57 | 2.340 |
Why?
| Pregnancy, High-Risk | 10 | 2021 | 49 | 1.860 |
Why?
| Diabetes, Gestational | 6 | 2024 | 52 | 1.810 |
Why?
| Pregnancy Complications, Neoplastic | 3 | 2024 | 23 | 1.680 |
Why?
| Military Personnel | 10 | 2013 | 163 | 1.660 |
Why?
| Birth Weight | 14 | 2020 | 106 | 1.650 |
Why?
| Parturition | 8 | 2023 | 49 | 1.650 |
Why?
| Risk Factors | 36 | 2025 | 3724 | 1.610 |
Why?
| Gynecology | 8 | 2022 | 48 | 1.560 |
Why?
| Labor, Obstetric | 11 | 2023 | 39 | 1.540 |
Why?
| Labor, Induced | 11 | 2020 | 16 | 1.490 |
Why?
| Fetal Growth Retardation | 10 | 2016 | 32 | 1.430 |
Why?
| Infant, Small for Gestational Age | 11 | 2024 | 32 | 1.430 |
Why?
| Hypertension | 8 | 2024 | 544 | 1.410 |
Why?
| Pregnancy Complications, Cardiovascular | 6 | 2024 | 29 | 1.400 |
Why?
| Pregnancy, Abdominal | 3 | 2015 | 9 | 1.340 |
Why?
| Uterine Diseases | 4 | 2020 | 10 | 1.290 |
Why?
| Surgical Wound Dehiscence | 2 | 2021 | 18 | 1.290 |
Why?
| Prospective Studies | 35 | 2024 | 2378 | 1.260 |
Why?
| Vaginal Birth after Cesarean | 4 | 2023 | 7 | 1.250 |
Why?
| Hemorrhage | 5 | 2023 | 197 | 1.240 |
Why?
| Rural Health Services | 4 | 2016 | 169 | 1.230 |
Why?
| Retrospective Studies | 46 | 2023 | 6263 | 1.210 |
Why?
| Congenital Abnormalities | 5 | 2021 | 112 | 1.180 |
Why?
| Peripartum Period | 4 | 2022 | 15 | 1.160 |
Why?
| Abortion, Spontaneous | 2 | 2022 | 16 | 1.150 |
Why?
| Young Adult | 37 | 2024 | 4102 | 1.150 |
Why?
| Pregnancy Complications, Infectious | 6 | 2021 | 75 | 1.140 |
Why?
| Postpartum Period | 10 | 2024 | 102 | 1.130 |
Why?
| Pregnancy Trimester, Third | 11 | 2022 | 50 | 1.120 |
Why?
| Twins | 7 | 2014 | 20 | 1.110 |
Why?
| Obesity, Morbid | 2 | 2018 | 78 | 1.110 |
Why?
| Obstetric Labor, Premature | 9 | 2016 | 25 | 1.080 |
Why?
| Fetal Weight | 6 | 2014 | 10 | 1.070 |
Why?
| Ultrasonography | 13 | 2023 | 435 | 1.000 |
Why?
| Pregnancy Complications, Hematologic | 5 | 2021 | 13 | 1.000 |
Why?
| Restless Legs Syndrome | 1 | 2025 | 11 | 0.970 |
Why?
| Dye Dilution Technique | 5 | 2014 | 14 | 0.960 |
Why?
| Dystocia | 8 | 2014 | 9 | 0.950 |
Why?
| Ultrasonography, Doppler, Color | 4 | 2019 | 31 | 0.950 |
Why?
| Referral and Consultation | 5 | 2015 | 288 | 0.940 |
Why?
| Fetal Death | 5 | 2022 | 20 | 0.930 |
Why?
| Fetus | 4 | 2020 | 183 | 0.920 |
Why?
| Fetal Macrosomia | 9 | 2015 | 17 | 0.900 |
Why?
| Body Mass Index | 12 | 2020 | 677 | 0.890 |
Why?
| Uterine Prolapse | 1 | 2023 | 3 | 0.880 |
Why?
| Morbidity | 4 | 2023 | 130 | 0.870 |
Why?
| Parity | 14 | 2020 | 43 | 0.870 |
Why?
| Uterus | 6 | 2023 | 85 | 0.860 |
Why?
| Pelvic Girdle Pain | 1 | 2023 | 2 | 0.860 |
Why?
| Antihypertensive Agents | 4 | 2024 | 125 | 0.850 |
Why?
| Esophageal Neoplasms | 1 | 2024 | 106 | 0.850 |
Why?
| Adrenal Gland Diseases | 1 | 2023 | 8 | 0.830 |
Why?
| Surgical Wound Infection | 5 | 2017 | 115 | 0.830 |
Why?
| Health Services Accessibility | 4 | 2021 | 424 | 0.830 |
Why?
| Adrenal Insufficiency | 1 | 2023 | 18 | 0.820 |
Why?
| Adenomyosis | 1 | 2022 | 1 | 0.820 |
Why?
| Domestic Violence | 3 | 2012 | 20 | 0.800 |
Why?
| Maternal Death | 1 | 2022 | 7 | 0.790 |
Why?
| Rural Population | 4 | 2022 | 554 | 0.790 |
Why?
| Maternal Mortality | 5 | 2020 | 24 | 0.790 |
Why?
| Cystitis | 1 | 2022 | 18 | 0.780 |
Why?
| Health Status Disparities | 2 | 2022 | 202 | 0.770 |
Why?
| Hyperparathyroidism | 1 | 2022 | 31 | 0.760 |
Why?
| Arkansas | 14 | 2022 | 1985 | 0.760 |
Why?
| Time Factors | 21 | 2024 | 2935 | 0.750 |
Why?
| Privacy | 1 | 2021 | 16 | 0.740 |
Why?
| Stomach Neoplasms | 1 | 2024 | 189 | 0.740 |
Why?
| Postmenopause | 1 | 2022 | 96 | 0.740 |
Why?
| Fetal Distress | 10 | 2020 | 10 | 0.740 |
Why?
| Communication Barriers | 1 | 2021 | 31 | 0.730 |
Why?
| Spinal Cord Injuries | 1 | 2021 | 53 | 0.710 |
Why?
| Practice Guidelines as Topic | 10 | 2020 | 468 | 0.700 |
Why?
| Respiratory Distress Syndrome, Newborn | 4 | 2017 | 49 | 0.700 |
Why?
| Torsion Abnormality | 1 | 2020 | 4 | 0.690 |
Why?
| Education, Medical | 1 | 2022 | 112 | 0.690 |
Why?
| Umbilical Cord | 1 | 2020 | 34 | 0.680 |
Why?
| Medically Underserved Area | 1 | 2020 | 47 | 0.670 |
Why?
| Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.670 |
Why?
| Placenta Diseases | 1 | 2019 | 13 | 0.660 |
Why?
| Adolescent | 31 | 2022 | 6443 | 0.660 |
Why?
| Health Personnel | 2 | 2020 | 247 | 0.650 |
Why?
| Adrenal Cortex Hormones | 2 | 2017 | 99 | 0.650 |
Why?
| Disease Management | 1 | 2021 | 178 | 0.650 |
Why?
| Simplexvirus | 1 | 2019 | 11 | 0.640 |
Why?
| Urinary Bladder Calculi | 1 | 2018 | 4 | 0.640 |
Why?
| Women's Health Services | 1 | 2019 | 15 | 0.630 |
Why?
| Herpes Simplex | 1 | 2019 | 21 | 0.630 |
Why?
| Military Medicine | 1 | 2019 | 22 | 0.630 |
Why?
| Lymphatic Metastasis | 1 | 2019 | 222 | 0.630 |
Why?
| Obesity | 5 | 2020 | 1121 | 0.620 |
Why?
| Fetal Mortality | 3 | 2015 | 7 | 0.620 |
Why?
| Uterine Inversion | 1 | 2018 | 1 | 0.620 |
Why?
| Stillbirth | 4 | 2022 | 28 | 0.610 |
Why?
| Cervical Ripening | 5 | 2016 | 6 | 0.610 |
Why?
| Intensive Care Units, Neonatal | 3 | 2015 | 124 | 0.600 |
Why?
| Women, Working | 2 | 2012 | 4 | 0.600 |
Why?
| Patient Satisfaction | 3 | 2023 | 278 | 0.580 |
Why?
| Diverticulum | 1 | 2017 | 21 | 0.570 |
Why?
| Internship and Residency | 2 | 2022 | 447 | 0.570 |
Why?
| Pregnancy, Twin | 2 | 2014 | 6 | 0.570 |
Why?
| Mass Screening | 4 | 2012 | 344 | 0.560 |
Why?
| Prenatal Diagnosis | 4 | 2022 | 97 | 0.560 |
Why?
| Stroke | 1 | 2022 | 495 | 0.550 |
Why?
| Predictive Value of Tests | 17 | 2019 | 930 | 0.550 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 150 | 0.550 |
Why?
| Uterine Retroversion | 1 | 2016 | 2 | 0.540 |
Why?
| Prevalence | 8 | 2025 | 971 | 0.530 |
Why?
| Blood Loss, Surgical | 3 | 2012 | 68 | 0.530 |
Why?
| Brachial Plexus Neuropathies | 2 | 2014 | 10 | 0.530 |
Why?
| Fish Products | 1 | 2016 | 2 | 0.530 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2016 | 4 | 0.530 |
Why?
| Pregnant Women | 4 | 2023 | 72 | 0.530 |
Why?
| Gastroschisis | 1 | 2016 | 38 | 0.520 |
Why?
| Heart Rate, Fetal | 10 | 2016 | 56 | 0.520 |
Why?
| Foodborne Diseases | 1 | 2016 | 12 | 0.520 |
Why?
| Genetic Counseling | 1 | 2016 | 41 | 0.520 |
Why?
| Mississippi | 8 | 2015 | 85 | 0.500 |
Why?
| Adenocarcinoma | 1 | 2019 | 397 | 0.500 |
Why?
| Genetic Testing | 1 | 2016 | 120 | 0.500 |
Why?
| Incidence | 8 | 2025 | 1032 | 0.500 |
Why?
| Death Certificates | 1 | 2015 | 17 | 0.490 |
Why?
| Fetal Monitoring | 9 | 2013 | 34 | 0.490 |
Why?
| Tertiary Care Centers | 2 | 2015 | 76 | 0.490 |
Why?
| Birth Certificates | 1 | 2015 | 25 | 0.490 |
Why?
| Cervix Uteri | 3 | 2011 | 42 | 0.490 |
Why?
| Odds Ratio | 9 | 2016 | 551 | 0.490 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 6 | 0.480 |
Why?
| Fetal Blood | 6 | 2010 | 66 | 0.480 |
Why?
| Catheterization | 3 | 2011 | 101 | 0.480 |
Why?
| Randomized Controlled Trials as Topic | 8 | 2021 | 573 | 0.480 |
Why?
| Magnetic Resonance Imaging | 4 | 2022 | 1548 | 0.470 |
Why?
| Chorionic Gonadotropin | 1 | 2014 | 18 | 0.470 |
Why?
| Pregnancy Trimester, First | 1 | 2014 | 22 | 0.460 |
Why?
| Automobile Driving | 1 | 2014 | 22 | 0.460 |
Why?
| Fractures, Bone | 3 | 2014 | 109 | 0.460 |
Why?
| Lung Neoplasms | 2 | 2019 | 601 | 0.450 |
Why?
| Tocolytic Agents | 5 | 2015 | 7 | 0.450 |
Why?
| Blood Pressure | 5 | 2024 | 531 | 0.440 |
Why?
| Sensitivity and Specificity | 12 | 2017 | 859 | 0.430 |
Why?
| Posture | 2 | 2005 | 65 | 0.430 |
Why?
| Truth Disclosure | 1 | 2013 | 14 | 0.430 |
Why?
| Guideline Adherence | 3 | 2013 | 136 | 0.430 |
Why?
| Algorithms | 4 | 2013 | 625 | 0.430 |
Why?
| Spouse Abuse | 2 | 2012 | 9 | 0.420 |
Why?
| Brain Injuries | 1 | 2014 | 159 | 0.410 |
Why?
| Apgar Score | 11 | 2018 | 26 | 0.400 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 105 | 0.400 |
Why?
| Ideal Body Weight | 1 | 2012 | 6 | 0.400 |
Why?
| Body Weights and Measures | 1 | 2012 | 17 | 0.400 |
Why?
| Magnesium Sulfate | 5 | 2016 | 9 | 0.390 |
Why?
| Rupture, Spontaneous | 2 | 2022 | 19 | 0.390 |
Why?
| Pilot Projects | 4 | 2022 | 698 | 0.390 |
Why?
| Exercise | 2 | 2009 | 516 | 0.380 |
Why?
| Hydroxyprogesterones | 3 | 2021 | 5 | 0.380 |
Why?
| Pregnancy Trimester, Second | 6 | 2020 | 20 | 0.380 |
Why?
| Gravidity | 3 | 2020 | 5 | 0.380 |
Why?
| Contraception | 1 | 2011 | 29 | 0.370 |
Why?
| Reproducibility of Results | 5 | 2021 | 1197 | 0.370 |
Why?
| Nifedipine | 3 | 2024 | 24 | 0.370 |
Why?
| Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.370 |
Why?
| Levonorgestrel | 1 | 2011 | 4 | 0.370 |
Why?
| Case-Control Studies | 10 | 2023 | 1156 | 0.360 |
Why?
| United States | 17 | 2023 | 4955 | 0.360 |
Why?
| Multivariate Analysis | 5 | 2014 | 583 | 0.350 |
Why?
| Aerospace Medicine | 1 | 2010 | 3 | 0.350 |
Why?
| Fluid Therapy | 2 | 2018 | 75 | 0.350 |
Why?
| Infant Mortality | 7 | 2013 | 57 | 0.350 |
Why?
| Blood Transfusion | 3 | 2021 | 129 | 0.350 |
Why?
| Tocolysis | 3 | 2015 | 3 | 0.350 |
Why?
| Pregnancy, Multiple | 2 | 2007 | 18 | 0.350 |
Why?
| Quality of Life | 3 | 2023 | 851 | 0.350 |
Why?
| HELLP Syndrome | 4 | 2007 | 4 | 0.340 |
Why?
| Triage | 4 | 2024 | 60 | 0.340 |
Why?
| Treatment Outcome | 10 | 2024 | 5283 | 0.330 |
Why?
| Diagnosis, Differential | 5 | 2019 | 1033 | 0.330 |
Why?
| Battered Women | 1 | 2009 | 3 | 0.320 |
Why?
| Cohort Studies | 11 | 2021 | 1452 | 0.320 |
Why?
| Clinical Competence | 3 | 2022 | 398 | 0.320 |
Why?
| Acidosis | 3 | 2004 | 36 | 0.320 |
Why?
| Regression Analysis | 3 | 2018 | 382 | 0.320 |
Why?
| Anemia, Sickle Cell | 2 | 2021 | 94 | 0.310 |
Why?
| Middle Aged | 12 | 2022 | 12611 | 0.310 |
Why?
| Bibliometrics | 1 | 2008 | 16 | 0.310 |
Why?
| Publishing | 1 | 2008 | 40 | 0.300 |
Why?
| Hospitalization | 4 | 2024 | 675 | 0.300 |
Why?
| Chorioamnionitis | 4 | 2017 | 15 | 0.290 |
Why?
| Homocysteine | 1 | 2008 | 127 | 0.290 |
Why?
| Amnion | 3 | 2020 | 9 | 0.270 |
Why?
| Risk Assessment | 9 | 2019 | 1270 | 0.270 |
Why?
| Hospitals | 2 | 2020 | 173 | 0.270 |
Why?
| Hypercalcemia | 1 | 2006 | 33 | 0.260 |
Why?
| Remote Consultation | 2 | 2017 | 28 | 0.260 |
Why?
| Birth Injuries | 4 | 2013 | 10 | 0.260 |
Why?
| Prognosis | 6 | 2018 | 1978 | 0.260 |
Why?
| Umbilical Arteries | 5 | 2006 | 15 | 0.260 |
Why?
| Version, Fetal | 1 | 2005 | 1 | 0.250 |
Why?
| Oxytocin | 2 | 2005 | 18 | 0.250 |
Why?
| Lifting | 1 | 2005 | 2 | 0.250 |
Why?
| Renal Insufficiency | 1 | 2006 | 110 | 0.250 |
Why?
| Smoking | 4 | 2018 | 507 | 0.250 |
Why?
| Noise | 1 | 2005 | 39 | 0.250 |
Why?
| Brachial Plexus | 3 | 2013 | 11 | 0.240 |
Why?
| Placenta, Retained | 2 | 2016 | 3 | 0.240 |
Why?
| Terbutaline | 2 | 2008 | 6 | 0.240 |
Why?
| Cerebral Palsy | 2 | 2016 | 38 | 0.240 |
Why?
| Labetalol | 1 | 2024 | 2 | 0.230 |
Why?
| Chorion | 1 | 2004 | 1 | 0.230 |
Why?
| Noise, Occupational | 1 | 2024 | 3 | 0.230 |
Why?
| Coloring Agents | 1 | 2004 | 66 | 0.230 |
Why?
| Patient Care Team | 3 | 2021 | 258 | 0.220 |
Why?
| Home Infusion Therapy | 1 | 2003 | 1 | 0.220 |
Why?
| Urinary Tract Infections | 1 | 2023 | 51 | 0.210 |
Why?
| Intensive Care, Neonatal | 1 | 2003 | 22 | 0.210 |
Why?
| Confidence Intervals | 5 | 2016 | 154 | 0.210 |
Why?
| Labor Stage, First | 4 | 2015 | 7 | 0.210 |
Why?
| Blood Volume | 2 | 2018 | 69 | 0.210 |
Why?
| Chorionic Villi | 2 | 2019 | 3 | 0.210 |
Why?
| Abortion, Therapeutic | 1 | 2002 | 3 | 0.200 |
Why?
| Logistic Models | 5 | 2011 | 900 | 0.200 |
Why?
| Pubic Symphysis | 2 | 2015 | 3 | 0.200 |
Why?
| Exudates and Transudates | 1 | 2002 | 4 | 0.200 |
Why?
| Hospitals, Military | 2 | 2014 | 7 | 0.200 |
Why?
| Intrauterine Devices | 2 | 2012 | 4 | 0.200 |
Why?
| Exercise Therapy | 1 | 2023 | 96 | 0.200 |
Why?
| Sutures | 1 | 2002 | 39 | 0.200 |
Why?
| Medicaid | 4 | 2023 | 252 | 0.200 |
Why?
| Hospitals, Teaching | 2 | 2020 | 54 | 0.200 |
Why?
| Embryo Implantation | 1 | 2002 | 7 | 0.200 |
Why?
| Chi-Square Distribution | 5 | 2012 | 277 | 0.200 |
Why?
| Acute Disease | 2 | 2022 | 373 | 0.190 |
Why?
| Drainage | 1 | 2002 | 79 | 0.190 |
Why?
| Hematoma | 1 | 2002 | 64 | 0.190 |
Why?
| Male | 14 | 2022 | 25907 | 0.190 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 8 | 0.190 |
Why?
| Emergency Service, Hospital | 2 | 2024 | 484 | 0.190 |
Why?
| Infant, Newborn, Diseases | 2 | 2013 | 56 | 0.190 |
Why?
| Weight Gain | 3 | 2013 | 237 | 0.190 |
Why?
| Mothers | 2 | 2017 | 257 | 0.190 |
Why?
| Licensure | 1 | 2021 | 14 | 0.190 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2021 | 13 | 0.190 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 110 | 0.190 |
Why?
| Technology | 1 | 2021 | 20 | 0.180 |
Why?
| Reproductive Health | 1 | 2021 | 8 | 0.180 |
Why?
| Risk Adjustment | 1 | 2021 | 16 | 0.180 |
Why?
| Maternal Age | 4 | 2015 | 41 | 0.180 |
Why?
| Progestins | 2 | 2012 | 11 | 0.180 |
Why?
| Fatal Outcome | 2 | 2019 | 197 | 0.180 |
Why?
| Hysterectomy | 4 | 2021 | 88 | 0.180 |
Why?
| Antithrombin Proteins | 1 | 2020 | 1 | 0.180 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.180 |
Why?
| Prolapse | 1 | 2020 | 6 | 0.180 |
Why?
| Puerperal Disorders | 2 | 2015 | 22 | 0.180 |
Why?
| Maternal Health Services | 1 | 2021 | 29 | 0.180 |
Why?
| Sleep | 1 | 2002 | 181 | 0.180 |
Why?
| Patient Care Planning | 1 | 2020 | 66 | 0.170 |
Why?
| Quality Improvement | 1 | 2022 | 209 | 0.170 |
Why?
| Surrogate Mothers | 1 | 2019 | 4 | 0.170 |
Why?
| Chest Pain | 1 | 2019 | 55 | 0.170 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1610 | 0.170 |
Why?
| ROC Curve | 6 | 2016 | 226 | 0.160 |
Why?
| Uterine Cervical Incompetence | 2 | 2011 | 2 | 0.160 |
Why?
| Misoprostol | 3 | 2016 | 5 | 0.160 |
Why?
| Oxytocics | 3 | 2016 | 6 | 0.160 |
Why?
| Cerclage, Cervical | 2 | 2011 | 8 | 0.160 |
Why?
| Dyspnea | 1 | 2019 | 75 | 0.160 |
Why?
| Abdominal Pain | 1 | 2020 | 83 | 0.160 |
Why?
| Honduras | 1 | 2019 | 1 | 0.160 |
Why?
| Probability | 5 | 2008 | 164 | 0.160 |
Why?
| Guatemala | 1 | 2019 | 4 | 0.160 |
Why?
| Office Visits | 2 | 2013 | 44 | 0.160 |
Why?
| Mental Health Services | 1 | 2022 | 202 | 0.160 |
Why?
| Contraception Behavior | 1 | 2019 | 10 | 0.160 |
Why?
| Colombia | 1 | 2019 | 15 | 0.160 |
Why?
| Acyclovir | 1 | 2019 | 9 | 0.160 |
Why?
| Lithotripsy, Laser | 1 | 2018 | 6 | 0.160 |
Why?
| Reference Values | 3 | 2019 | 307 | 0.160 |
Why?
| Critical Illness | 1 | 2021 | 302 | 0.160 |
Why?
| Tomography, X-Ray Computed | 3 | 2022 | 1164 | 0.160 |
Why?
| Internet | 1 | 2021 | 259 | 0.160 |
Why?
| Australia | 3 | 2012 | 86 | 0.160 |
Why?
| Term Birth | 2 | 2008 | 15 | 0.150 |
Why?
| Child | 2 | 2023 | 6906 | 0.150 |
Why?
| Obstetric Surgical Procedures | 1 | 2018 | 2 | 0.150 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 86 | 0.150 |
Why?
| Wounds and Injuries | 3 | 2009 | 287 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2010 | 475 | 0.150 |
Why?
| Vaginosis, Bacterial | 2 | 2011 | 8 | 0.150 |
Why?
| Fetal Development | 2 | 2016 | 50 | 0.150 |
Why?
| Fibronectins | 2 | 2011 | 38 | 0.150 |
Why?
| Early Diagnosis | 1 | 2018 | 88 | 0.150 |
Why?
| Age Factors | 3 | 2011 | 1110 | 0.150 |
Why?
| Glucose Tolerance Test | 2 | 2010 | 58 | 0.150 |
Why?
| Postoperative Complications | 4 | 2017 | 1033 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2023 | 601 | 0.150 |
Why?
| Medical Records | 3 | 2014 | 85 | 0.140 |
Why?
| Chronic Disease | 3 | 2024 | 573 | 0.140 |
Why?
| Aged | 3 | 2022 | 9741 | 0.140 |
Why?
| Pyelonephritis | 1 | 2017 | 5 | 0.140 |
Why?
| Antiviral Agents | 1 | 2019 | 170 | 0.140 |
Why?
| Depression | 2 | 2017 | 582 | 0.140 |
Why?
| Actinomyces | 1 | 2017 | 10 | 0.140 |
Why?
| Actinomycosis | 1 | 2017 | 10 | 0.140 |
Why?
| Indomethacin | 2 | 2015 | 38 | 0.140 |
Why?
| Self-Injurious Behavior | 1 | 2017 | 28 | 0.140 |
Why?
| Malpractice | 2 | 2008 | 16 | 0.140 |
Why?
| Antioxidants | 1 | 2019 | 239 | 0.140 |
Why?
| Telephone | 2 | 2017 | 69 | 0.140 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 409 | 0.140 |
Why?
| Brain Waves | 1 | 2016 | 16 | 0.130 |
Why?
| Kidney | 1 | 2021 | 696 | 0.130 |
Why?
| Symptom Assessment | 1 | 2016 | 32 | 0.130 |
Why?
| Patient Care Management | 1 | 2016 | 18 | 0.130 |
Why?
| Systole | 1 | 2016 | 72 | 0.130 |
Why?
| Puerperal Infection | 3 | 2005 | 5 | 0.130 |
Why?
| Suicidal Ideation | 1 | 2017 | 97 | 0.130 |
Why?
| Biophysical Phenomena | 2 | 2014 | 18 | 0.130 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2016 | 3 | 0.130 |
Why?
| Colposcopy | 1 | 2016 | 17 | 0.130 |
Why?
| Socioeconomic Factors | 2 | 2016 | 591 | 0.130 |
Why?
| Magnetoencephalography | 1 | 2016 | 86 | 0.130 |
Why?
| Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.130 |
Why?
| Hospitals, Community | 2 | 2014 | 19 | 0.130 |
Why?
| Humeral Fractures | 2 | 2013 | 8 | 0.130 |
Why?
| Clavicle | 2 | 2013 | 6 | 0.130 |
Why?
| Amniocentesis | 3 | 2004 | 5 | 0.130 |
Why?
| Hospitals, University | 2 | 2014 | 77 | 0.130 |
Why?
| Urologic Diseases | 1 | 2015 | 10 | 0.120 |
Why?
| Neuroprotective Agents | 1 | 2016 | 99 | 0.120 |
Why?
| Anticonvulsants | 1 | 2016 | 123 | 0.120 |
Why?
| Hydrogen-Ion Concentration | 5 | 2011 | 168 | 0.120 |
Why?
| Endometritis | 3 | 2010 | 5 | 0.120 |
Why?
| Drug Implants | 2 | 2011 | 35 | 0.120 |
Why?
| Episiotomy | 1 | 2014 | 6 | 0.120 |
Why?
| Sheep | 1 | 2014 | 86 | 0.120 |
Why?
| Safety | 1 | 2015 | 77 | 0.120 |
Why?
| Southwestern United States | 1 | 2014 | 16 | 0.120 |
Why?
| Louisiana | 1 | 2014 | 39 | 0.110 |
Why?
| Pregnancy in Diabetics | 3 | 2010 | 26 | 0.110 |
Why?
| Southeastern United States | 1 | 2014 | 47 | 0.110 |
Why?
| Oxidative Stress | 1 | 2019 | 772 | 0.110 |
Why?
| Physician-Patient Relations | 2 | 2013 | 142 | 0.110 |
Why?
| Clinical Protocols | 2 | 2012 | 110 | 0.110 |
Why?
| Health Care Costs | 1 | 2015 | 167 | 0.110 |
Why?
| Academic Medical Centers | 1 | 2014 | 149 | 0.110 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 266 | 0.110 |
Why?
| Body Weight | 2 | 2013 | 517 | 0.110 |
Why?
| Insulin-Like Growth Factor II | 2 | 2010 | 17 | 0.110 |
Why?
| Healthy People Programs | 1 | 2013 | 3 | 0.110 |
Why?
| Brain Diseases | 2 | 2005 | 83 | 0.110 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 276 | 0.110 |
Why?
| Counseling | 1 | 2014 | 134 | 0.110 |
Why?
| Depression, Postpartum | 1 | 2013 | 43 | 0.110 |
Why?
| Follow-Up Studies | 5 | 2017 | 2242 | 0.100 |
Why?
| Image Enhancement | 1 | 2013 | 54 | 0.100 |
Why?
| Adnexa Uteri | 1 | 2012 | 1 | 0.100 |
Why?
| Digestive System | 1 | 2012 | 15 | 0.100 |
Why?
| Retroperitoneal Space | 1 | 2012 | 27 | 0.100 |
Why?
| Abdominal Wall | 1 | 2012 | 12 | 0.100 |
Why?
| Linear Models | 4 | 2021 | 279 | 0.100 |
Why?
| Peritoneum | 1 | 2012 | 17 | 0.100 |
Why?
| Trial of Labor | 4 | 2008 | 4 | 0.100 |
Why?
| Government Agencies | 1 | 2012 | 15 | 0.100 |
Why?
| Birth Rate | 1 | 2012 | 4 | 0.100 |
Why?
| Mandatory Reporting | 1 | 2012 | 11 | 0.100 |
Why?
| Local Government | 1 | 2012 | 22 | 0.100 |
Why?
| Hematocrit | 1 | 2012 | 43 | 0.100 |
Why?
| Hemoglobins | 1 | 2013 | 109 | 0.100 |
Why?
| Return to Work | 1 | 2012 | 11 | 0.100 |
Why?
| Reference Standards | 1 | 2012 | 52 | 0.100 |
Why?
| Attitude of Health Personnel | 3 | 2012 | 352 | 0.100 |
Why?
| Patient Care | 1 | 2012 | 58 | 0.100 |
Why?
| Motor Activity | 1 | 2013 | 225 | 0.100 |
Why?
| Administration, Oral | 3 | 2024 | 434 | 0.100 |
Why?
| Desogestrel | 1 | 2011 | 2 | 0.100 |
Why?
| Urination | 1 | 2011 | 19 | 0.100 |
Why?
| Contraceptive Agents, Female | 1 | 2011 | 5 | 0.100 |
Why?
| Infant | 4 | 2023 | 3628 | 0.100 |
Why?
| Osmolar Concentration | 1 | 2011 | 62 | 0.100 |
Why?
| Reproductive History | 1 | 2011 | 4 | 0.100 |
Why?
| Emotions | 1 | 2013 | 168 | 0.100 |
Why?
| Drug Eruptions | 1 | 2011 | 13 | 0.100 |
Why?
| Traction | 1 | 2011 | 7 | 0.090 |
Why?
| Personal Satisfaction | 1 | 2012 | 78 | 0.090 |
Why?
| Guidelines as Topic | 1 | 2012 | 109 | 0.090 |
Why?
| Surgical Sponges | 1 | 2011 | 6 | 0.090 |
Why?
| Labor Stage, Second | 2 | 2008 | 3 | 0.090 |
Why?
| Periodicals as Topic | 2 | 2010 | 58 | 0.090 |
Why?
| Deglutition | 1 | 2011 | 43 | 0.090 |
Why?
| Fetal Proteins | 1 | 2011 | 4 | 0.090 |
Why?
| Medical Errors | 1 | 2011 | 23 | 0.090 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.090 |
Why?
| Communication | 1 | 2013 | 250 | 0.090 |
Why?
| Weight-Bearing | 1 | 2011 | 46 | 0.090 |
Why?
| Energy Metabolism | 1 | 2013 | 286 | 0.090 |
Why?
| Metronidazole | 1 | 2011 | 28 | 0.090 |
Why?
| Receptor, IGF Type 2 | 1 | 2010 | 4 | 0.090 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 491 | 0.090 |
Why?
| Family Practice | 1 | 2012 | 102 | 0.090 |
Why?
| Severity of Illness Index | 4 | 2010 | 978 | 0.090 |
Why?
| Appendicitis | 2 | 2009 | 61 | 0.090 |
Why?
| RNA, Untranslated | 1 | 2010 | 13 | 0.090 |
Why?
| Hemodynamics | 1 | 2012 | 265 | 0.090 |
Why?
| Qualitative Research | 1 | 2013 | 349 | 0.090 |
Why?
| Hypersensitivity | 1 | 2011 | 75 | 0.090 |
Why?
| Foreign Bodies | 1 | 2011 | 63 | 0.090 |
Why?
| International Classification of Diseases | 1 | 2010 | 63 | 0.090 |
Why?
| Length of Stay | 3 | 2021 | 629 | 0.090 |
Why?
| Aviation | 1 | 2010 | 5 | 0.090 |
Why?
| Anti-Bacterial Agents | 3 | 2023 | 745 | 0.090 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 3 | 0.090 |
Why?
| Monitoring, Physiologic | 1 | 2011 | 118 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 95 | 0.090 |
Why?
| Pelvis | 2 | 2015 | 66 | 0.080 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2010 | 54 | 0.080 |
Why?
| Perinatal Care | 2 | 2020 | 25 | 0.080 |
Why?
| Cardiac Complexes, Premature | 1 | 2009 | 3 | 0.080 |
Why?
| Clothing | 1 | 2009 | 4 | 0.080 |
Why?
| Naval Medicine | 1 | 2009 | 4 | 0.080 |
Why?
| Uterine Contraction | 2 | 2008 | 30 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 71 | 0.080 |
Why?
| Exercise Tolerance | 1 | 2009 | 42 | 0.080 |
Why?
| Social Perception | 1 | 2009 | 27 | 0.080 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.080 |
Why?
| Marital Status | 1 | 2009 | 18 | 0.080 |
Why?
| Physicians | 2 | 2012 | 232 | 0.080 |
Why?
| Physician's Role | 1 | 2009 | 48 | 0.080 |
Why?
| Longitudinal Studies | 1 | 2011 | 735 | 0.080 |
Why?
| Research Design | 2 | 2008 | 353 | 0.080 |
Why?
| Medical History Taking | 1 | 2009 | 48 | 0.080 |
Why?
| Pregnancy, Prolonged | 1 | 2008 | 1 | 0.080 |
Why?
| Patient Preference | 1 | 2009 | 40 | 0.080 |
Why?
| Anthropometry | 2 | 2006 | 95 | 0.080 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 253 | 0.080 |
Why?
| Attitude to Death | 1 | 2008 | 12 | 0.080 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 38 | 0.080 |
Why?
| Surgical Procedures, Operative | 1 | 2009 | 67 | 0.080 |
Why?
| Emergency Treatment | 2 | 2008 | 30 | 0.080 |
Why?
| Cardiotocography | 2 | 2005 | 6 | 0.080 |
Why?
| Pregnancy, Ectopic | 1 | 2008 | 9 | 0.080 |
Why?
| Asphyxia Neonatorum | 2 | 2010 | 8 | 0.080 |
Why?
| Brain | 1 | 2016 | 1319 | 0.080 |
Why?
| Fecal Incontinence | 1 | 2008 | 12 | 0.070 |
Why?
| Societies, Medical | 2 | 2006 | 187 | 0.070 |
Why?
| Constipation | 1 | 2008 | 34 | 0.070 |
Why?
| Genomic Imprinting | 1 | 2007 | 8 | 0.070 |
Why?
| Administration, Intravenous | 2 | 2020 | 70 | 0.070 |
Why?
| Perinatal Mortality | 2 | 2020 | 3 | 0.070 |
Why?
| Lung | 1 | 2011 | 504 | 0.070 |
Why?
| Double-Blind Method | 3 | 2020 | 708 | 0.070 |
Why?
| Nurse's Role | 1 | 2007 | 69 | 0.070 |
Why?
| Breast Feeding | 1 | 2009 | 189 | 0.070 |
Why?
| Body Size | 1 | 2007 | 26 | 0.070 |
Why?
| Forecasting | 1 | 2007 | 147 | 0.070 |
Why?
| Abdomen | 2 | 2006 | 75 | 0.070 |
Why?
| Antacids | 1 | 2006 | 11 | 0.070 |
Why?
| Workload | 1 | 2006 | 45 | 0.070 |
Why?
| Stress, Psychological | 1 | 2008 | 266 | 0.070 |
Why?
| Ludwig's Angina | 1 | 2006 | 1 | 0.070 |
Why?
| Creatinine | 1 | 2006 | 145 | 0.070 |
Why?
| Gastroesophageal Reflux | 1 | 2006 | 50 | 0.070 |
Why?
| Breech Presentation | 1 | 2005 | 1 | 0.060 |
Why?
| Mesothelioma | 1 | 2005 | 19 | 0.060 |
Why?
| Comorbidity | 2 | 2023 | 623 | 0.060 |
Why?
| Leptin | 1 | 2007 | 143 | 0.060 |
Why?
| Hemostasis, Surgical | 1 | 2005 | 11 | 0.060 |
Why?
| Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 7 | 0.060 |
Why?
| Sepsis | 2 | 2009 | 225 | 0.060 |
Why?
| Uterine Neoplasms | 1 | 2005 | 60 | 0.060 |
Why?
| Acid-Base Imbalance | 1 | 2005 | 1 | 0.060 |
Why?
| Gene Frequency | 3 | 2010 | 97 | 0.060 |
Why?
| Liver Neoplasms | 1 | 2009 | 326 | 0.060 |
Why?
| Insulin | 1 | 2007 | 467 | 0.060 |
Why?
| Patient Admission | 1 | 2005 | 76 | 0.060 |
Why?
| Analgesics | 1 | 2006 | 116 | 0.060 |
Why?
| Colonic Pseudo-Obstruction | 1 | 2004 | 3 | 0.060 |
Why?
| Infant, Premature, Diseases | 2 | 2020 | 93 | 0.060 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 62 | 0.060 |
Why?
| Hypoglycemia | 1 | 2005 | 55 | 0.060 |
Why?
| Pain, Postoperative | 1 | 2006 | 163 | 0.060 |
Why?
| Workplace | 1 | 2005 | 93 | 0.060 |
Why?
| Proteins | 1 | 2007 | 339 | 0.060 |
Why?
| Statistics, Nonparametric | 3 | 2011 | 192 | 0.060 |
Why?
| Calcium | 1 | 2006 | 398 | 0.060 |
Why?
| Pelvic Inflammatory Disease | 1 | 2004 | 8 | 0.060 |
Why?
| Thrombophlebitis | 1 | 2004 | 24 | 0.060 |
Why?
| Arterial Pressure | 1 | 2024 | 45 | 0.060 |
Why?
| Palliative Care | 1 | 2006 | 190 | 0.060 |
Why?
| Glycoproteins | 1 | 2004 | 116 | 0.050 |
Why?
| Urogenital System | 1 | 2003 | 5 | 0.050 |
Why?
| Pregnancy Trimesters | 2 | 2017 | 13 | 0.050 |
Why?
| Infusion Pumps | 1 | 2003 | 13 | 0.050 |
Why?
| Drug Administration Schedule | 3 | 2011 | 370 | 0.050 |
Why?
| Cesarean Section, Repeat | 1 | 2003 | 5 | 0.050 |
Why?
| Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.050 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 52 | 0.050 |
Why?
| Outpatients | 1 | 2004 | 117 | 0.050 |
Why?
| Propionates | 1 | 2003 | 22 | 0.050 |
Why?
| Emergency Medical Services | 1 | 2003 | 110 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2003 | 213 | 0.050 |
Why?
| Multiple Organ Failure | 1 | 2003 | 48 | 0.050 |
Why?
| Pregnancy Tests | 1 | 2002 | 2 | 0.050 |
Why?
| Kidney Diseases | 1 | 2005 | 213 | 0.050 |
Why?
| Autopsy | 1 | 2022 | 47 | 0.050 |
Why?
| Hospital Costs | 1 | 2003 | 72 | 0.050 |
Why?
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2002 | 4 | 0.050 |
Why?
| Ovarian Diseases | 1 | 2002 | 2 | 0.050 |
Why?
| Heart Diseases | 1 | 2005 | 214 | 0.050 |
Why?
| Tissue Expansion | 1 | 2002 | 4 | 0.050 |
Why?
| Dinoprostone | 1 | 2002 | 47 | 0.050 |
Why?
| Health Promotion | 1 | 2005 | 258 | 0.050 |
Why?
| Surgical Instruments | 1 | 2002 | 27 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 30 | 0.050 |
Why?
| Contrast Media | 1 | 2003 | 192 | 0.050 |
Why?
| Recurrence | 1 | 2003 | 659 | 0.050 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 342 | 0.050 |
Why?
| Seizures | 1 | 2003 | 195 | 0.050 |
Why?
| Emergencies | 1 | 2021 | 79 | 0.040 |
Why?
| Intensive Care Units | 1 | 2021 | 225 | 0.040 |
Why?
| Reoperation | 1 | 2002 | 460 | 0.040 |
Why?
| Embryo Transfer | 1 | 2019 | 18 | 0.040 |
Why?
| Mental Health | 1 | 2022 | 228 | 0.040 |
Why?
| Animals | 1 | 2014 | 13124 | 0.040 |
Why?
| Risk | 2 | 2013 | 324 | 0.040 |
Why?
| Placentation | 1 | 2019 | 12 | 0.040 |
Why?
| Genotype | 2 | 2010 | 533 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2020 | 476 | 0.040 |
Why?
| Trophoblasts | 1 | 2019 | 29 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 217 | 0.040 |
Why?
| Treatment Failure | 2 | 2009 | 118 | 0.040 |
Why?
| Georgia | 1 | 2017 | 41 | 0.040 |
Why?
| APACHE | 1 | 2017 | 23 | 0.040 |
Why?
| Nicotine | 1 | 2018 | 184 | 0.040 |
Why?
| Betamethasone | 1 | 2016 | 3 | 0.030 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 182 | 0.030 |
Why?
| Transportation | 1 | 2016 | 28 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 318 | 0.030 |
Why?
| Psychometrics | 1 | 2017 | 232 | 0.030 |
Why?
| Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.030 |
Why?
| Obstetrical Forceps | 1 | 2015 | 4 | 0.030 |
Why?
| Rupture | 1 | 2015 | 24 | 0.030 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 151 | 0.030 |
Why?
| Fracture Fixation | 1 | 2015 | 17 | 0.030 |
Why?
| Urogenital Abnormalities | 1 | 2015 | 17 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 349 | 0.030 |
Why?
| Suppositories | 1 | 2015 | 1 | 0.030 |
Why?
| Administration, Rectal | 1 | 2015 | 10 | 0.030 |
Why?
| Sexual Behavior | 1 | 2016 | 117 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 303 | 0.030 |
Why?
| Radiography | 1 | 2015 | 485 | 0.030 |
Why?
| Glucocorticoids | 1 | 2016 | 230 | 0.030 |
Why?
| South Carolina | 1 | 2014 | 21 | 0.030 |
Why?
| Dexamethasone | 1 | 2016 | 432 | 0.030 |
Why?
| Drug Administration Routes | 1 | 2013 | 10 | 0.030 |
Why?
| New Zealand | 1 | 2012 | 18 | 0.020 |
Why?
| Auscultation | 1 | 2012 | 9 | 0.020 |
Why?
| Health Care Surveys | 1 | 2012 | 175 | 0.020 |
Why?
| Canada | 1 | 2012 | 105 | 0.020 |
Why?
| Self Report | 1 | 2013 | 206 | 0.020 |
Why?
| Patient Safety | 1 | 2012 | 102 | 0.020 |
Why?
| Oximetry | 1 | 2012 | 68 | 0.020 |
Why?
| Vagina | 1 | 2011 | 43 | 0.020 |
Why?
| Area Under Curve | 1 | 2011 | 179 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 226 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 234 | 0.020 |
Why?
| Chromogranins | 1 | 2010 | 5 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 14 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2010 | 22 | 0.020 |
Why?
| Injections, Intramuscular | 1 | 2009 | 48 | 0.020 |
Why?
| Medical Informatics | 1 | 2010 | 54 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2010 | 162 | 0.020 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 55 | 0.020 |
Why?
| Appendectomy | 1 | 2009 | 33 | 0.020 |
Why?
| Administration, Intravaginal | 1 | 2008 | 5 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 108 | 0.020 |
Why?
| Virginia | 1 | 2008 | 19 | 0.020 |
Why?
| Flatulence | 1 | 2008 | 3 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 139 | 0.020 |
Why?
| Shoulder | 1 | 2008 | 18 | 0.020 |
Why?
| Rectum | 1 | 2008 | 52 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2007 | 36 | 0.020 |
Why?
| Shoulder Fractures | 1 | 2007 | 7 | 0.020 |
Why?
| Pedigree | 1 | 2007 | 119 | 0.020 |
Why?
| Pelvic Floor | 1 | 2008 | 51 | 0.020 |
Why?
| Haplotypes | 1 | 2007 | 84 | 0.020 |
Why?
| Data Collection | 1 | 2008 | 280 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 39 | 0.020 |
Why?
| False Positive Reactions | 1 | 2007 | 59 | 0.020 |
Why?
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 5 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2008 | 227 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2005 | 41 | 0.020 |
Why?
| Insurance, Liability | 1 | 2005 | 1 | 0.020 |
Why?
| Compensation and Redress | 1 | 2005 | 2 | 0.020 |
Why?
| Liability, Legal | 1 | 2005 | 12 | 0.020 |
Why?
| Diagnosis-Related Groups | 1 | 2005 | 18 | 0.020 |
Why?
| Registries | 1 | 2008 | 563 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2005 | 16 | 0.020 |
Why?
| Diastole | 1 | 2005 | 70 | 0.020 |
Why?
| Washington | 1 | 2005 | 47 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 198 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 99 | 0.020 |
Why?
| Pain Measurement | 1 | 2006 | 270 | 0.010 |
Why?
| Cecostomy | 1 | 2004 | 4 | 0.010 |
Why?
| Biophysics | 1 | 2004 | 15 | 0.010 |
Why?
| Phenotype | 1 | 2007 | 739 | 0.010 |
Why?
| Delivery Rooms | 1 | 2004 | 1 | 0.010 |
Why?
| Leukocyte Count | 1 | 2004 | 69 | 0.010 |
Why?
| Maternal Welfare | 1 | 2004 | 8 | 0.010 |
Why?
| Wound Infection | 1 | 2004 | 27 | 0.010 |
Why?
| Decision Making | 1 | 2006 | 272 | 0.010 |
Why?
| Suicide | 1 | 2005 | 83 | 0.010 |
Why?
| Databases, Factual | 1 | 2007 | 673 | 0.010 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2004 | 27 | 0.010 |
Why?
| Injury Severity Score | 1 | 2004 | 164 | 0.010 |
Why?
| Vancomycin | 1 | 2004 | 79 | 0.010 |
Why?
| Resuscitation | 1 | 2003 | 74 | 0.010 |
Why?
| Eclampsia | 1 | 2003 | 1 | 0.010 |
Why?
| Polyunsaturated Alkamides | 1 | 2003 | 2 | 0.010 |
Why?
| Heparin | 1 | 2004 | 91 | 0.010 |
Why?
| Fever | 1 | 2004 | 112 | 0.010 |
Why?
| Blood Gas Analysis | 1 | 2003 | 30 | 0.010 |
Why?
| Liver | 1 | 2009 | 1132 | 0.010 |
Why?
| Neutrophils | 1 | 2004 | 145 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 2004 | 125 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2006 | 1372 | 0.010 |
Why?
| Organ Size | 1 | 2003 | 223 | 0.010 |
Why?
| Hypothyroidism | 1 | 2003 | 56 | 0.010 |
Why?
| Tachycardia, Paroxysmal | 1 | 2002 | 8 | 0.010 |
Why?
| Gels | 1 | 2002 | 17 | 0.010 |
Why?
| Physical Examination | 1 | 2003 | 93 | 0.010 |
Why?
| Laparotomy | 1 | 2002 | 35 | 0.010 |
Why?
| Ovariectomy | 1 | 2002 | 115 | 0.010 |
Why?
| Infant, Premature | 1 | 2004 | 317 | 0.010 |
Why?
| Survival Analysis | 1 | 2002 | 661 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2006 | 575 | 0.010 |
Why?
| Asthma | 1 | 2003 | 284 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|